Login to Your Account



MGI Pharma Buys Out Guilford For $177.5M In Cash, Stock

By Randall Osborne


Friday, July 22, 2005
About a week after reporting solid second-quarter sales for its anti-nausea drug Aloxi for chemotherapy patients, MGI Pharmaceuticals Inc. disclosed its plan to buy out Guilford Pharmaceuticals Inc. for $177.5 million in cash and stock - thus adding to its cancer portfolio and more. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription